Cao, Yingdan, Fenghao Shi, Yuantong Li, Xiaoxia Wei, Hongbin Yi, and Sheng Han. 2024. “Cost-Effectiveness Analysis of the Combination of Low-Dose Nivolumab With Triple Metronomic Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma in China”. Health Decision 2 (S1). https://doi.org/10.54844/hd.2024.0008.